---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-033842"
form_type: "8-K"
ticker: "ASH"
cik: "0001674862"
company_name: "ASHLAND INC."
filed_at: "2026-02-02T23:59:59+00:00"
generated_at: "2026-05-16T05:37:43.866253+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ashland Q1 sales down 5% to $386M; narrows FY2026 EBITDA guidance to $400–420M

## Summary
- Net loss of $12M (($0.26)/diluted share); Adjusted EPS excl. intangibles amortization $0.26.
- Adjusted EBITDA of $58M (15% margin), down 5% YoY; Avoca divestiture reduced sales ~$10M.
- Calvert City startup delay and weather disruptions caused ~$10M Adjusted EBITDA hit, isolated to Q2.
- Life Sciences grew YoY; Personal Care and Specialty Additives declined; pricing down 2%.
- Cash flow from ops $125M (including $103M tax refund); Ongoing Free Cash Flow $26M.

## SEC filing metadata
- accession: 0001193125-26-033842
- form_type: 8-K
- ticker: ASH
- cik: 0001674862
- company_name: ASHLAND INC.
- filed_at: 2026-02-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674862/000119312526033842/0001193125-26-033842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674862/000119312526033842/ash-20260202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-033842
- JSON: https://secwatch.observer/filing/0001193125-26-033842.json
- Plain text: https://secwatch.observer/filing/0001193125-26-033842.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.